Skip to main content

Table 1 Characteristics of patients with non-small-cell lung cancer (NSCLC) who completed the SF-36 and QLQ C-30 health-related quality of life (HRQoL) surveys

From: Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients’ survival

 

SF-36 (n = 230)

QLQ C-30 (n = 230)

 

Mean ± SD

n [%]

Mean ± SD

n [%]

Age

60.2 ± 10.7

 

60.1 ± 10.7

 

Sex:

    

  - Men

 

186 [80.9]

 

184 [80.0]

  - Women

 

44 [19.1]

 

46 [20.0]

Stage of cancer

    

  - I or II

 

49 [21.3]

 

48 [20.9]

  - III

 

136 [59.1]

 

141 [61.3]

  - IV

 

45 [19.6]

 

41 [17.8]

Treatments before the HRQoL measurement

  

  - Chemotherapy only

133 [57.8)

 

132 [57.4]

  - Radiotherapy only or with chemotherapy

26 [11.3]

 

24 [10.4]

  - Surgery alone or surgery and (radiotherapy or chemotherapy)

71 [30.9]

 

74 [32.2]

Education level

    

  - Primary

 

64 [28.7]

 

64 [29.6]

  - Secondary

 

144 [64.6]

 

136 [63.0]

  - Post-secondary

 

15 [6.7]

 

16 [7.4]

  1. SF-36 = Medical Outcomes Survey Short Form 36; QLQ C-30 = European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30.
  2. Treatments before HRQoL measurement were divided into 3 classes for all Cox multivariate models:
  3. 1) Chemotherapy only.
  4. 2) Radiotherapy or chemotherapy or both.
  5. 3) Surgery alone or surgery and radiotherapy or chemotherapy.